Statements (63)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:test_subjects
|
| gptkbp:approves |
gptkb:U._S._Food_and_Drug_Administration
|
| gptkbp:associated_with |
increased screening rates
|
| gptkbp:available_in |
gptkb:United_States
|
| gptkbp:can_detect |
hemoglobin
DNA markers |
| gptkbp:can_lead_to |
earlier detection of cancer
reduction in colorectal cancer mortality |
| gptkbp:care_instructions |
collect stool sample at home
|
| gptkbp:clinical_trial |
conducted to evaluate effectiveness
|
| gptkbp:developed_by |
gptkb:Exact_Sciences_Corporation
increase screening compliance |
| gptkbp:events |
colonoscopy if positive result
|
| gptkbp:first_introduced |
gptkb:2014
|
| gptkbp:frequency |
every three years
|
| gptkbp:has_limitations |
false positives
false negatives |
| https://www.w3.org/2000/01/rdf-schema#label |
Cologuard
|
| gptkbp:influenced_by |
guidelines from American Cancer Society
guidelines from U. S. Preventive Services Task Force |
| gptkbp:is |
a diagnostic test
a replacement for colonoscopy |
| gptkbp:is_available_in |
various healthcare settings
|
| gptkbp:is_compared_to |
other non-invasive tests
traditional stool tests |
| gptkbp:is_designed_to |
be user-friendly
|
| gptkbp:is_opposed_by |
colonoscopy
|
| gptkbp:is_part_of |
colorectal cancer prevention strategies
|
| gptkbp:is_promoted_through |
gptkb:advertising_campaigns
healthcare providers |
| gptkbp:is_recommended_by |
gptkb:healthcare_professionals
|
| gptkbp:is_recommended_for |
adults aged 45 and older
|
| gptkbp:is_subject_to |
regulatory oversight
|
| gptkbp:is_tested_for |
clinical studies
|
| gptkbp:is_used_by |
patients at average risk
patients at increased risk |
| gptkbp:marketed_as |
a convenient screening option
|
| gptkbp:packaging |
prepaid return shipping
|
| gptkbp:part_of |
preventive health care
|
| gptkbp:patient_education |
on interpreting results
on proper sample collection |
| gptkbp:performance |
high sensitivity for colorectal cancer
moderate sensitivity for advanced adenomas |
| gptkbp:requires |
prescription
|
| gptkbp:requires_follow_up |
for abnormal results
|
| gptkbp:results_reported_in |
about 2 weeks
|
| gptkbp:sampled_in |
stool sample
|
| gptkbp:suitable_for |
individuals with certain gastrointestinal conditions
individuals with a history of colorectal cancer individuals with certain genetic syndromes individuals with prior colon surgery |
| gptkbp:supports |
patient autonomy in screening choices
|
| gptkbp:test_kit_contains |
instruction booklet
collection container preservative solution return shipping label |
| gptkbp:type |
non-invasive test
|
| gptkbp:used_for |
colorectal cancer screening
|
| gptkbp:utilizes |
molecular biology techniques
laboratory analysis of stool samples |
| gptkbp:bfsParent |
gptkb:Exact_Sciences
gptkb:Exact_Sciences_Corporation |
| gptkbp:bfsLayer |
7
|